Improved safety with intravenous insulin therapy for critically ill patients with renal failure

Roland Dickerson, Allison M. Lynch, George O. Maish, Martin Croce, Gayle Minard, Rex O. Brown

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: The aim of this study was to evaluate the safety and efficacy of a new intravenous (IV) regular human insulin infusion (RHI) algorithm for glycemic control in critically ill patients with renal failure. Methods: Adult trauma patients with renal failure who received a new RHI algorithm were compared with those who received the discontinued RHI algorithm (historical control). Target blood glucose (BG) concentration was 70 to 149 mg/dL (3.9-8.3 mmol/L). Patients were evaluated for 7 d while receiving the RHI infusion and continuous enteral or parenteral nutrition. Results: Mean BG was higher for the new RHI algorithm group (n = 25) compared with control (n=21): 145 ± 10 mg/dL or 8.1 ± 0.6 mmol/L versus 133 ± 14 mg/dL or 7.4 ± 0.8 mmol/L (P = 0.001). The new RHI algorithm resulted in less time within the target BG range (11.9 ± 2.5 h/d versus 16.1 ± 3.3 h/d; P = 0.001); however, BGs were within 70 to 179 mg/dL (or 3.9-10 mmol/L) for 16.3 ± 2.6 h/d. The proportion of patients who experienced an episode of moderate hypoglycemia (BG 40-60 mg/dL or 2.2-3.3 mmol/L) or severe hypoglycemia (BG < 40 mg/dL or 2.2 mmol/L) was decreased (32% versus 76%; P = 0.001) and eliminated (0% versus 29%, P = 0.006), respectively. Conclusions: The new RHI algorithm improved patient safety by decreasing the prevalence of moderate hypoglycemia and eliminating severe hypoglycemia. The duration of glycemic control within the target BG range was decreased, but acceptable within a higher target BG ceiling.

Original languageEnglish (US)
Pages (from-to)557-562
Number of pages6
JournalNutrition
Volume30
Issue number5
DOIs
StatePublished - Jan 1 2014

Fingerprint

Insulin, Regular, Human
Critical Illness
Renal Insufficiency
Blood Glucose
Insulin
Safety
Hypoglycemia
Therapeutics
Parenteral Nutrition
Enteral Nutrition
Patient Safety
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Improved safety with intravenous insulin therapy for critically ill patients with renal failure. / Dickerson, Roland; Lynch, Allison M.; Maish, George O.; Croce, Martin; Minard, Gayle; Brown, Rex O.

In: Nutrition, Vol. 30, No. 5, 01.01.2014, p. 557-562.

Research output: Contribution to journalArticle

Dickerson, Roland ; Lynch, Allison M. ; Maish, George O. ; Croce, Martin ; Minard, Gayle ; Brown, Rex O. / Improved safety with intravenous insulin therapy for critically ill patients with renal failure. In: Nutrition. 2014 ; Vol. 30, No. 5. pp. 557-562.
@article{c29677d0506b42949987d7f6ef23e49c,
title = "Improved safety with intravenous insulin therapy for critically ill patients with renal failure",
abstract = "Objective: The aim of this study was to evaluate the safety and efficacy of a new intravenous (IV) regular human insulin infusion (RHI) algorithm for glycemic control in critically ill patients with renal failure. Methods: Adult trauma patients with renal failure who received a new RHI algorithm were compared with those who received the discontinued RHI algorithm (historical control). Target blood glucose (BG) concentration was 70 to 149 mg/dL (3.9-8.3 mmol/L). Patients were evaluated for 7 d while receiving the RHI infusion and continuous enteral or parenteral nutrition. Results: Mean BG was higher for the new RHI algorithm group (n = 25) compared with control (n=21): 145 ± 10 mg/dL or 8.1 ± 0.6 mmol/L versus 133 ± 14 mg/dL or 7.4 ± 0.8 mmol/L (P = 0.001). The new RHI algorithm resulted in less time within the target BG range (11.9 ± 2.5 h/d versus 16.1 ± 3.3 h/d; P = 0.001); however, BGs were within 70 to 179 mg/dL (or 3.9-10 mmol/L) for 16.3 ± 2.6 h/d. The proportion of patients who experienced an episode of moderate hypoglycemia (BG 40-60 mg/dL or 2.2-3.3 mmol/L) or severe hypoglycemia (BG < 40 mg/dL or 2.2 mmol/L) was decreased (32{\%} versus 76{\%}; P = 0.001) and eliminated (0{\%} versus 29{\%}, P = 0.006), respectively. Conclusions: The new RHI algorithm improved patient safety by decreasing the prevalence of moderate hypoglycemia and eliminating severe hypoglycemia. The duration of glycemic control within the target BG range was decreased, but acceptable within a higher target BG ceiling.",
author = "Roland Dickerson and Lynch, {Allison M.} and Maish, {George O.} and Martin Croce and Gayle Minard and Brown, {Rex O.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.nut.2013.10.010",
language = "English (US)",
volume = "30",
pages = "557--562",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Improved safety with intravenous insulin therapy for critically ill patients with renal failure

AU - Dickerson, Roland

AU - Lynch, Allison M.

AU - Maish, George O.

AU - Croce, Martin

AU - Minard, Gayle

AU - Brown, Rex O.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: The aim of this study was to evaluate the safety and efficacy of a new intravenous (IV) regular human insulin infusion (RHI) algorithm for glycemic control in critically ill patients with renal failure. Methods: Adult trauma patients with renal failure who received a new RHI algorithm were compared with those who received the discontinued RHI algorithm (historical control). Target blood glucose (BG) concentration was 70 to 149 mg/dL (3.9-8.3 mmol/L). Patients were evaluated for 7 d while receiving the RHI infusion and continuous enteral or parenteral nutrition. Results: Mean BG was higher for the new RHI algorithm group (n = 25) compared with control (n=21): 145 ± 10 mg/dL or 8.1 ± 0.6 mmol/L versus 133 ± 14 mg/dL or 7.4 ± 0.8 mmol/L (P = 0.001). The new RHI algorithm resulted in less time within the target BG range (11.9 ± 2.5 h/d versus 16.1 ± 3.3 h/d; P = 0.001); however, BGs were within 70 to 179 mg/dL (or 3.9-10 mmol/L) for 16.3 ± 2.6 h/d. The proportion of patients who experienced an episode of moderate hypoglycemia (BG 40-60 mg/dL or 2.2-3.3 mmol/L) or severe hypoglycemia (BG < 40 mg/dL or 2.2 mmol/L) was decreased (32% versus 76%; P = 0.001) and eliminated (0% versus 29%, P = 0.006), respectively. Conclusions: The new RHI algorithm improved patient safety by decreasing the prevalence of moderate hypoglycemia and eliminating severe hypoglycemia. The duration of glycemic control within the target BG range was decreased, but acceptable within a higher target BG ceiling.

AB - Objective: The aim of this study was to evaluate the safety and efficacy of a new intravenous (IV) regular human insulin infusion (RHI) algorithm for glycemic control in critically ill patients with renal failure. Methods: Adult trauma patients with renal failure who received a new RHI algorithm were compared with those who received the discontinued RHI algorithm (historical control). Target blood glucose (BG) concentration was 70 to 149 mg/dL (3.9-8.3 mmol/L). Patients were evaluated for 7 d while receiving the RHI infusion and continuous enteral or parenteral nutrition. Results: Mean BG was higher for the new RHI algorithm group (n = 25) compared with control (n=21): 145 ± 10 mg/dL or 8.1 ± 0.6 mmol/L versus 133 ± 14 mg/dL or 7.4 ± 0.8 mmol/L (P = 0.001). The new RHI algorithm resulted in less time within the target BG range (11.9 ± 2.5 h/d versus 16.1 ± 3.3 h/d; P = 0.001); however, BGs were within 70 to 179 mg/dL (or 3.9-10 mmol/L) for 16.3 ± 2.6 h/d. The proportion of patients who experienced an episode of moderate hypoglycemia (BG 40-60 mg/dL or 2.2-3.3 mmol/L) or severe hypoglycemia (BG < 40 mg/dL or 2.2 mmol/L) was decreased (32% versus 76%; P = 0.001) and eliminated (0% versus 29%, P = 0.006), respectively. Conclusions: The new RHI algorithm improved patient safety by decreasing the prevalence of moderate hypoglycemia and eliminating severe hypoglycemia. The duration of glycemic control within the target BG range was decreased, but acceptable within a higher target BG ceiling.

UR - http://www.scopus.com/inward/record.url?scp=84897431037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897431037&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2013.10.010

DO - 10.1016/j.nut.2013.10.010

M3 - Article

VL - 30

SP - 557

EP - 562

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 5

ER -